1. Norton AE, Broyles AD. Management of children with hypersensitivity and monoclonal antibodies. Immunol Allergy Clin North Am. 2017;37: 713–725.
2. Hoetzenecker W, Nägeli M, Mehra ET, et al. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016;38:75–86.
3. Aberer W, Bircher A, Romano A, et al; European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58:854–863.
4. Romano A, Caubet JC. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014;2:3–12.
5. Moreno E, Laffond E, Muñoz-Bellido FJ, et al. Using β-lactam antibiotics in patients with a history of β-lactam allergy: current concepts. Pol Arch Intern Med. 2017;127:540–549.
6. Mori F, Cianferoni A, Barni S, et al. Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions. J Allergy Clin Immunol Pract. 2015;3:375–380.e1.
7. Thompson DF, Ramos CL. Antibiotic-induced rash in patients with infectious mononucleosis. Ann Pharmacother. 2017;51:154–162.
8. Ponvert C, Perrin Y, Bados-Albiero A, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22:411–418.
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.